Systemic gene transfer reveals distinctive muscle transduction profile of tyrosine mutant AAV-1, -6, and -9 in neonatal dogs

Molecular Therapy Methods and Clinical Development

Volumn 1, Issue , 2014, Pages 14002-

  Hakim, Chady H ^a   Yue, Yongping ^a   Shin, Jin Hong ^a,c   Williams, Regina R ^b   Zhang, Keqing ^a   Smith, Bruce F ^b   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

^b AUBURN UNIVERSITY   (United States)

^c Yangsan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; NEUTRALIZING ANTIBODY; TYROSINE; UNCLASSIFIED DRUG; Y445F; Y731F;

ADENO ASSOCIATED VIRUS 1; ADENO ASSOCIATED VIRUS 6; ADENO ASSOCIATED VIRUS 9; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANINE MODEL; CARDIAC MUSCLE; ENZYME ACTIVITY; GENE TRANSFER; MOLECULAR GENETICS; MUSCULAR DYSTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ROUS SARCOMA VIRUS; SEROLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 85015631716     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2014.2     Document Type: Article

References (40)

1. 1 Rahimov, F, Kunkel, LM, The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol 201 (2013), 499–510.
2. 2 Flanigan, KM, The muscular dystrophies. Semin Neurol 32 (2012), 255–263.
3. 3 McNally, EM, Pytel, P, Muscle diseases: the muscular dystrophies. Annu Rev Pathol 2 (2007), 87–109.
4. 4 Kunkel, LM, 2004 William Allan Award address. Cloning of the DMD gene. Am J Hum Genet 76 (2005), 205–214.
5. 5 Davies, KE, Nowak, KJ, Molecular mechanisms of muscular dystrophies: old and new players. Nat Rev Mol Cell Biol 7 (2006), 762–773.
6. 6 Morgan, JE, Partridge, TA, Cell transplantation and gene therapy in muscular dystrophy. Bioessays 14 (1992), 641–645.
7. 7 Chamberlain, JS, X-linked dystrophies: from gene localization to gene therapy. Curr Opin Neurol Neurosurg 5 (1992), 610–614.
8. 8 Mendell, JR, Rodino-Klapac, L, Sahenk, Z, Malik, V, Kaspar, BK, Walker, CM, et al. Gene therapy for muscular dystrophy: lessons learned and path forward. Neurosci Lett 527 (2012), 90–99.
9. 9 Mingozzi, F, High, KA, Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12 (2011), 341–355.
10. 10 Gregorevic, P, Allen, JM, Minami, E, Blankinship, MJ, Haraguchi, M, Meuse, L, et al. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12 (2006), 787–789.
11. 11 Odom, GL, Gregorevic, P, Allen, JM, Chamberlain, JS, Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. Mol Ther 19 (2011), 36–45.
12. 12 Zhang, Y, Yue, Y, Li, L, Hakim, CH, Zhang, K, Thomas, GD, et al. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Hum Mol Genet 22 (2013), 3720–3729.
13. 13 Wang, B, Li, J, Fu, FH, Xiao, X, Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice. J Orthop Res 27 (2009), 421–426.
14. 14 Duan, D, Duchenne muscular dystrophy gene therapy: Lost in translation?. Res Rep Biol 2011 (2011), 31–42.
15. 15 Zhong, L, Li, B, Mah, CS, Govindasamy, L, Agbandje-McKenna, M, Cooper, M, et al. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci USA 105 (2008), 7827–7832.
16. 16 Qiao, C, Zhang, W, Yuan, Z, Shin, JH, Li, J, Jayandharan, GR, et al. Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Hum Gene Ther 21 (2010), 1343–1348.
17. 17 Petrs-Silva, H, Dinculescu, A, Li, Q, Min, SH, Chiodo, V, Pang, JJ, et al. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther 17 (2009), 463–471.
18. 18 Markusic, DM, Herzog, RW, Aslanidi, GV, Hoffman, BE, Li, B, Li, M, et al. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines. Mol Ther 18 (2010), 2048–2056.
19. 19 Dalkara, D, Byrne, LC, Lee, T, Hoffmann, NV, Schaffer, DV, Flannery, JG, Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9. Gene Ther 19 (2012), 176–181.
20. 20 Yue, Y, Ghosh, A, Long, C, Bostick, B, Smith, BF, Kornegay, JN, et al. A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther 16 (2008), 1944–1952.
21. 21 Shin, JH, Yue, Y, Smith, B, Duan, D, Humoral immunity to AAV-6, 8, and 9 in normal and dystrophic dogs. Hum Gene Ther 23 (2012), 287–294.
22. 22 Xiao, W, Chirmule, N, Berta, SC, McCullough, B, Gao, G, Wilson, JM, Gene therapy vectors based on adeno-associated virus type 1. J Virol 73 (1999), 3994–4003.
23. 23 Wang, Z, Zhu, T, Qiao, C, Zhou, L, Wang, B, Zhang, J, et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23 (2005), 321–328.
24. 24 Gregorevic, P, Blankinship, MJ, Allen, JM, Crawford, RW, Meuse, L, Miller, DG, et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10 (2004), 828–834.
25. 25 Bostick, B, Shin, JH, Yue, Y, Duan, D, AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice. Mol Ther 19 (2011), 1826–1832.
26. 26 Bostick, B, Yue, Y, Lai, Y, Long, C, Li, D, Duan, D, Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther 19 (2008), 851–856.
27. 27 Bostick, B, Shin, JH, Yue, Y, Wasala, NB, Lai, Y, Duan, D, AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J Mol Cell Cardiol 53 (2012), 217–222.
28. 28 Pan, X, Yue, Y, Zhang, K, Lostal, W, Shin, JH, Duan, D, Long-term robust myocardial transduction of the dog heart from a peripheral vein by adeno-associated virus serotype-8. Hum Gene Ther 24 (2013), 584–594.
29. 29 Kornegay, JN, Li, J, Bogan, JR, Bogan, DJ, Chen, C, Zheng, H, et al. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther 18 (2010), 1501–1508.
30. 30 Li, X, Eastman, EM, Schwartz, RJ, Draghia-Akli, R, Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat Biotechnol 17 (1999), 241–245.
31. 31 Brown, PA, Bodles-Brakhop, AM, Pope, MA, Draghia-Akli, R, Gene therapy by electroporation for the treatment of chronic renal failure in companion animals. BMC Biotechnol, 9, 2009, 4.
32. 32 Koo, T, Okada, T, Athanasopoulos, T, Foster, H, Takeda, S, Dickson, G, Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog. J Gene Med 13 (2011), 497–506.
33. 33 Rapti, K, Louis-Jeune, V, Kohlbrenner, E, Ishikawa, K, Ladage, D, Zolotukhin, S, et al. Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models. Mol Ther 20 (2012), 73–83.
34. 34 Denard, J, Beley, C, Kotin, R, Lai-Kuen, R, Blot, S, Leh, H, et al. Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6. J Virol 86 (2012), 6620–6631.
35. 35 Arnett, AL, Garikipati, D, Wang, Z, Tapscott, S, Chamberlain, JS, Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector. Front Microbiol, 2, 2011, 220.
36. 36 Gurda, BL, DiMattia, MA, Miller, EB, Bennett, A, McKenna, R, Weichert, WS, et al. Capsid antibodies to different adeno-associated virus serotypes bind common regions. J Virol 87 (2013), 9111–9124.
37. 37 Fine, DM, Shin, JH, Yue, Y, Volkmann, D, Leach, SB, Smith, BF, et al. Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs. Neuromuscul Disord 21 (2011), 453–461.
38. 38 Smith, BF, Yue, Y, Woods, PR, Kornegay, JN, Shin, JH, Williams, RR, et al. An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Lab Invest 91 (2011), 216–231.
39. 39 Shin, JH, Yue, Y, Duan, D, Recombinant adeno-associated viral vector production and purification. Methods Mol Biol 798 (2012), 267–284.
40. 40 Yue, Y, Shin, JH, Duan, D, Whole body skeletal muscle transduction in neonatal dogs with AAV-9. Methods Mol Biol 709 (2011), 313–329.